| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| eMed Technologies Corporation |
| 25 Hartwell Avenue, Lexington, MA 02421 * (781) 862-0000 |
| Business Description | The company is a leading provider of workflow solutions for electronically managing and distributing medical images and related information. |
|
Filing Information Not yet | |||
| To Trade As | EMDT (NASNTL) | Industry | Internet (SIC 7374) |
| Type of Stock Offered | Common Shares | Filing Date | 8/18/99 |
| Domestic Shares Filed | Filing Range | - | |
| Foreign Shares Filed | 0 | Offering Amount | $40,000,000 |
| Company Shares | Est. Expenses | - - | |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Bear, Stearns & Co. Inc. | Lead Manager | (212) 272-4850 |
| Donaldson, Lufkin & Jenrette Securities Corp. | Co-manager | (212) 371-0641 |
| Wit Capital Corporation | Co-manager | (212) 253-4400 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | - - Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/95 | 12/31/96 | 12/31/97 | 12/31/98 | 12/31/99 | ||
| Revenues | 0.466 | 1.009 | 8.027 | 12.594 | 23.571 | - | - |
| Income from Oper. | -2.133 | -3.655 | -5.179 | -4.964 | -2.405 | - | - |
| Net Income | -2.034 | -3.746 | -5.625 | -5.113 | -2.561 | - | - |
| E.P.S | -5.080 | -8.390 | -12.450 | -11.700 | -5.120 | - | - |
| Revenue Growth (%) | 116.52 | 695.54 | 56.90 | 87.161 | - | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -1.29 | - | - | ||||
| Cash Flow - Inv. | 46.28 | - | - | ||||
| Cash Flow - Fin. | 3.45 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 12/31/99 | Financial Ratios | ||||
| Total Assets | 13.28 | Current Assets | 12.04 | Current Ratio | 1.37 |
| Total Liab. | 8.85 | Current Liab. | 8.77 | Debt Ratio | 66.68% |
| Total Equity | 4.42 | Working Cap. | 3.26 | Debt to Equity Ratio | 2.00 |
| Cash | 4.46 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to repay indebtedness and for general corporate purposes including the expansion of our sales, marketing and development efforts and possibly acquisitions and partnerships. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Ropes & Gray |
| Bank's Law Firm | Skadden, Arps, Slate, Meagher & Flom |
| Registrar/Transfer Agent | American Stock Transfer & Trust Co |
| Auditor | Pricewaterhouse Coopers LLC |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Pacific Venture Group, L.P. and affiliated entity | 15.80 | |
| Three Arch Bay Health Sciences Fund and affiliated entities | 10.90 | |
| Delphi Ventures III, L.P. and affiliated entities | 10.90 | |
| Bedrock Capital Partners I, L.P. and affiliated entities | 10.20 | |
| Bessemer Venture Partners IV L.P. and related entities | 8.30 | |
| Seaflower BioVenture Fund II, LLC and an affiliated entity | 7.20 | |
| Note: represents ownership of 5% or more prior to the offering. | ||